CUDC-907 Terminated Phase 2 Trials for Poorly Differentiated and Undifferentiated Thyroid Cancer / Neoplasms, Thyroid / Differentiated Thyroid Cancer (DTC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03002623CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer